Sharon L. Paige

Sharon L. Paige

Auto-generated profile, based on publicly available information

Sharon L. Paige

Cardiovascular Institute, Stanford University School of Medicine, CA (S.P., S.W.).

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2021 in Circulation
Verified
Journal Article
Open access
PDF file
Markus KraneMarkus Krane
Markus Krane
MDMartina Dreßen
Martina Dreßen
GSGianluca Santamaria
Gianluca Santamaria
IMIlaria My
Ilaria My
CSChristine M. Schneider
Christine M. Schneider
AMAlessandra Moretti
Alessandra Moretti
Background: Complex molecular programs in specific cell lineages govern human heart development. Hypoplastic left heart syndrome (HLHS) is the most common and severe manifestation within the spectrum of left ventricular outflow tract obstruction defects occurring in association with ventricular hypoplasia. The pathogenesis of HLHS is unknown, but hemodynamic disturbances are assumed to play a prominent role. Methods: To identify perturbations in gene programs controlling ventricular muscle lineage development in HLHS, we performed whole-exome sequencing of 87 HLHS parent–offspring trios, nuclear transcriptomics of cardiomyocytes from ventricles of 4 patients with HLHS and 15 controls at different stages of heart development, single cell RNA sequencing, and 3D modeling in induced pluripotent stem cells from 3 patients with HLHS and 3 controls. Results: Gene set enrichment and protein network analyses of damaging de novo mutations and dysregulated genes from ventricles of patients with HLHS suggested alterations in specific gene programs and cellular processes critical during fetal ventricular cardiogenesis, including cell cycle and cardiomyocyte maturation. Single-cell and 3D modeling with induced pluripotent stem cells demonstrated intrinsic defects in the cell cycle/unfolded protein response/autophagy hub resulting in disrupted differentiation of early cardiac progenitor lineages leading to defective cardiomyocyte subtype differentiation/maturation in HLHS. Premature cell cycle exit of ventricular cardiomyocytes from patients with HLHS prevented normal tissue responses to developmental signals for growth, leading to multinucleation/polyploidy, accumulation of DNA damage, and exacerbated apoptosis, all potential drivers of left ventricular hypoplasia in absence of hemodynamic cues. Conclusions: Our results highlight that despite genetic heterogeneity in HLHS, many mutations converge on sequential cellular processes primarily driving cardiac myogenesis, suggesting novel therapeutic approaches.

20 October 2020 in Circulation
Verified
Journal Article
Closed access
PDF file
SPSharon L. Paige
Sharon L. Paige
FGFrancisco X. Galdos
Francisco X. Galdos
SLSoah Lee
Soah Lee
ECElizabeth T. Chin
Elizabeth T. Chin
SRSara Ranjbarvaziri
Sara Ranjbarvaziri
Sean WuSean Wu
Sean Wu

4 February 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
OCOrlando Chirikian
Orlando Chirikian
WGWilliam R. Goodyer
William R. Goodyer
EDElda Dzilic
Elda Dzilic
VSVahid Serpooshan
Vahid Serpooshan
JBJan W. Buikema
Jan W. Buikema
Sean WuSean Wu
Sean Wu
Generating cardiomyocytes (CMs) from human induced pluripotent stem cells (hiPSCs) has represented a significant advance in our ability to model cardiac disease. Current differentiation protocols, however, have limited use due to their production of heterogenous cell populations, primarily consisting of ventricular-like CMs. Here we describe the creation of two chamber-specific reporter hiPSC lines by site-directed genomic integration using CRISPR-Cas9 technology. In the MYL2-tdTomato reporter, the red fluorescent tdTomato was inserted upstream of the 3′ untranslated region of the Myosin Light Chain 2 (MYL2) gene in order faithfully label hiPSC-derived ventricular-like CMs while avoiding disruption of endogenous gene expression. Similarly, in the SLN-CFP reporter, Cyan Fluorescent Protein (CFP) was integrated downstream of the coding region of the atrial-specific gene, Sarcolipin (SLN). Purification of tdTomato+ and CFP+ CMs using flow cytometry coupled with transcriptional and functional characterization validated these genetic tools for their use in the isolation of bona fide ventricular-like and atrial-like CMs, respectively. Finally, we successfully generated a double reporter system allowing for the isolation of both ventricular and atrial CM subtypes within a single hiPSC line. These tools provide a platform for chamber-specific hiPSC-derived CM purification and analysis in the context of atrial- or ventricular-specific disease and therapeutic opportunities.

18 August 2020 in Circulation
Verified
Journal Article
Closed access
PDF file
HHHyunTae V. Hwang
HyunTae V. Hwang
NSNefthi Sandeep
Nefthi Sandeep
SPSharon L. Paige
Sharon L. Paige
SRSara Ranjbarvaziri
Sara Ranjbarvaziri
DHDong-Qing Hu
Dong-Qing Hu
SRSushma Reddy
Sushma Reddy
Background: In patients with complex congenital heart disease, such as those with tetralogy of Fallot, the right ventricle (RV) is subject to pressure overload stress, leading to RV hypertrophy and eventually RV failure. The role of lipid peroxidation, a potent form of oxidative stress, in mediating RV hypertrophy and failure in congenital heart disease is unknown. Methods: Lipid peroxidation and mitochondrial function and structure were assessed in right ventricle (RV) myocardium collected from patients with RV hypertrophy with normal RV systolic function (RV fractional area change, 47.3±3.8%) and in patients with RV failure showing decreased RV systolic function (RV fractional area change, 26.6±3.1%). The mechanism of the effect of lipid peroxidation, mediated by 4-hydroxynonenal ([4HNE] a byproduct of lipid peroxidation) on mitochondrial function and structure was assessed in HL1 murine cardiomyocytes and human induced pluripotent stem cell-derived cardiomyocytes. Results: RV failure was characterized by an increase in 4HNE adduction of metabolic and mitochondrial proteins (16 of 27 identified proteins), in particular electron transport chain proteins. Sarcomeric (myosin) and cytoskeletal proteins (desmin, tubulin) also underwent 4HNE adduction. RV failure showed lower oxidative phosphorylation (moderate RV hypertrophy, 287.6±19.75 versus RV failure, 137.8±11.57 pmol/[sec×mL]; P =0.0004), and mitochondrial structural damage. Using a cell model, we show that 4HNE decreases cell number and oxidative phosphorylation (control, 388.1±23.54 versus 4HNE, 143.7±11.64 pmol/[sec×mL]; P <0.0001). Carvedilol, a known antioxidant did not decrease 4HNE adduction of metabolic and mitochondrial proteins and did not improve oxidative phosphorylation. Conclusions: Metabolic, mitochondrial, sarcomeric, and cytoskeletal proteins are susceptible to 4HNE-adduction in patients with RV failure. 4HNE decreases mitochondrial oxygen consumption by inhibiting electron transport chain complexes. Carvedilol did not improve the 4HNE-mediated decrease in oxygen consumption. Strategies to decrease lipid peroxidation could improve mitochondrial energy generation and cardiomyocyte survival and improve RV failure in patients with congenital heart disease.

9 June 2020 in Genetics in Medicine
Verified
Journal Article
Closed access
PDF file
SPSharon L. Paige
Sharon L. Paige
KLKirstie M. Lechich
Kirstie M. Lechich
ETElif Seda Selamet Tierney
Elif Seda Selamet Tierney
RCR. Thomas Collins
R. Thomas Collins

28 March 2019 in Birth Defects Research
Verified
Journal Article
Closed access
PDF file
SPSharon L. Paige
Sharon L. Paige
WYWei Yang
Wei Yang
JPJames R. Priest
James R. Priest
LBLorenzo D. Botto
Lorenzo D. Botto
GSGary Shaw
Gary Shaw
TSthe National Birth Defects Prevention Study
the National Birth Defects Prevention Study